Printstack is a dynamic and responsive print outfit powered by technology and leveraging analytics to offer our esteemed print clients across all sectors improved print services. We refer to ourselves as a “Tech Print Company,” and our vision is to be “Smart beyond print”. We also offer easy-to-use customer-friendly technology to make access to service more desirable for our customers. Printstack is a customer-centric print company with a focus on good quality delivery offering both online and offline platforms, we are specialized in branding, commercial printing, marketing materials, clothing, apparel branding, signage, photo printing, and digital art products.

Nigerian Tech enthusiast Onyeoghani Godfrey co-founder of Coodens Lab has come out to caution Nigerians on the conspiracy of 5G vs Coronavirus on his twitter handle [url]@godfrey_inc[/url] "Before you join the argument on 5G vs Coronavirus do your research very well.
Understand Biology, Physics, Radio frequency and World politics.
If you could not stop Buhari from getting re-elected, can you stop 5G in Nigeria?
I guess you didn't even know when the test was carried out in Abuja and Lagos
Without the lock-down, if the government want to install anything can you stop them?
Let's get our argument right and backed with verifiable facts so we don't lose out and join in destroying humanity and the world
Hosea 4:6 My people are destroyed for lack of knowledge..."

https://twitter.com/godfrey_inc

According to the Cable, Some researchers at the Migal Galilee Research Institute (MIGAL) in Israel say they have developed an effective vaccine against avian coronavirus infectious bronchitis virus (IBV) and will soon create a human vaccine against coronavirus (COVID-19).

IBV is a disease affecting animals. The researchers said the vaccine against IBV has been proven in pre-clinical trials.

After four years of multi-disciplinary research funded by Israel’s ministry of science and technology in cooperation with Israel’s ministry of agriculture, MIGAL, on its website, the researchers said they have achieved a scientific breakthrough that will lead to the rapid creation of a vaccine against coronavirus.

MIGAL said it has now made required genetic adjustments to adapt the vaccine to COVID-19, the human strain of coronavirus, and is working to achieve the safety approvals that will enable in-vivo testing, enable the initiation of production of a vaccine to counter the coronavirus epidemic currently spreading throughout the world, which so far has claimed 2,666 lives.

Chen Katz, MIGAL’s biotechnology group leader, also said “the scientific framework for the vaccine is based on a new protein expression vector, which forms and secretes a chimeric soluble protein that delivers the viral antigen into mucosal tissues by self-activated endocytosis (a cellular process in which substances are brought into a cell by surrounding the material with cell membrane, forming a vesicle containing the ingested material), causing the body to form antibodies against the virus. In pre-clinical (IN-VIVO) trials, MIGAL’s researchers have demonstrated that the oral vaccination induces high levels of specific anti-IBV antibodies.”

Follow Lifepoint Medical Centre for more update



From MIGAL research, it was discovered that the poultry coronavirus has high genetic similarity to the human COVID-19, and that it uses the same infection mechanism, a fact that increases the likelihood of achieving an effective human vaccine in a very short period of time.

“Given the urgent global need for a human coronavirus vaccine, we are doing everything we can to accelerate development. Our goal is to produce the vaccine during the next 8-10 weeks, and to achieve safety approval in 90 days,” David Zigdon, MIGAL’s chief executive officer, said.

“This will be an oral vaccine, making it particularly accessible to the general public. We are currently in intensive discussions with potential partners that can help accelerate the in-human trials phase and expedite the completion final product development and regulatory activities.”

According to Dr. Kalu this vaccine will save humanity from imminent extinction

INTRODUCTION TO IN VITRO FERTILIZATION (IVF)
1. INDICATIONS FOR IVF
Assisted reproduction technology encompasses several techniques to by-pass the problems preventing conception through the normal sexual intercourse in a stable relationship. The commonest assisted reproduction method is IVF. This refers to the assemblage of procedure culminating in the retrieval of human oocyte(eggs) which is approximated to potentiated spermatozoa in a test tube (In vitro) in a laboratory condition equilibrated to the same physiological condition as obtains in the normal human environment (in vivo, within the womb). It thus involves fertilization outside the human body and without sexual intercourse.
In vitro Fertilization (IVF) has enhanced the possibility of pregnancy even in situations thought to be impossible until four decades ago when the first baby, Louisa Brown in Great Manchester City, United Kingdom, was born using this technology.
When selecting cases for IVF, the initial diagnostic approach is directed at separating absolutely infertile patients from potentially fertile ones. For example, in cases of bilateral blockage of the Fallopian tubes that are not repairable, refractory (not responsive) anovulation (absence of ovulation), absence of motile sperm or very low sperm count, the couple is absolutely infertile and IVF is the only option.
Those who are potentially fertile are treatable by artificial insemination(IUI) but may fail to conceive after a period of time, appropriate for their age( due to defective egg, sperm, or embryo; patent but malfunctioned tubes; failure of fertilization), IVF is the only alternative as there are no tests to confirm these barriers.
Female Factor
The female is said to have the problem in 30% of cases of infertility, the male also in 30% while 20% is from the contribution by both parties. The commonest cause of infertility, particularly in our environment is tubal problems and most patients requiring IVF suffer from tubal disease. Tubal surgery is usually not an effective, especially where there is peritubal adhesions, thickening of the tubal wall, irreparable damage to the ciliary epithelium within the tubes, and severely damaged fimbria (ends) of the tube. When there is pathological swelling of one or both tubes, Hydrosalpinx, may result in a 50% decline in implantation rate during IVF and may require surgery prior to the procedure. A high level of chlamydial antibody indicates tubal disease as Chlamydia can present as an asymptomatic infection while causing silent ciliary damage in the tubes.
Chances of successful IVF are less in abnormally shaped uterine cavities than in a normally shaped small uterine cavity. Hence fibroid encroaching into the uterine cavity should be removed prior to IVF.
Another condition that may require IVF is endometriosis, a situation where active endometrial tissues (Tissues that line the womb of a woman) are found anywhere other than the endometrial cavity. In this condition, the IVF results are similar no matter the severity of the condition, and the success rate is less than that of women with tubal factor.
Age is a major determinant of fertility outcome. This is due to the waning ovarian that is associated with aging. In advanced ovarian age, as detected by increased cycle day 3 FSH(Follicle Stimulating Hormone) or Estradiol levels, there is reduced IVF outcome and egg donation or modified IVF stimulation protocols are alternatives.
Male factor
If the total sperm count is < 10million, sperm motility is < 30%, or there is abnormal spermatozoon morphology >60%, IVF is indicated. In severe male factor infertility, either of the obstructive or non-obstructive type, micromanipulation techniques can be used with IVF to achieve pregnancy.
In the presence of anti-sperm antibodies, if there is no conception with immunosuppressive drugs, the use of condoms and IUI patients are advised for IVF.
In unexplained infertility, if the patient fails to conceive after 6 cycles of IUI and superovulation(use of drugs to increase the number of follicles that get to maturation in each cycle), or if the woman is greater than 35 years, IVF is advised.
IVF gives better results in young women and success declines in women greater than 40 years due to oocyte problems like genetic or chromosomal defects. Age factor, therefore, should be kept in mind while selecting cases for IVF.
Good physical and emotional condition of the patient improves success rate because of a better response to medication. If there are an existing medical condition, like diabetes mellitus, kidney or liver diseases, prior consultation with a medical specialist is necessary.
In certain situations like premature menopause( menopause before the age of 40 years), when there are genetic disorders, following radiation therapy, or if the ovaries are not available for pickup due to adhesions, parenthood is possible using donor egg or embryo.
Finally, alternatives to IVF exists and must be considered. Surrogacy and adoption are veritable options that should be offered to couples in the face of repeated IVF failures or where IVF is not possible or the results are considered suboptimal.

Find out follow Life Point Fertility Centre Abuja on all social media platform

INTRODUCTION TO IN VITRO FERTILIZATION (IVF)
1. INDICATIONS FOR IVF
Assisted reproduction technology encompasses several techniques to by-pass the problems preventing conception through the normal sexual intercourse in a stable relationship. The commonest assisted reproduction method is IVF. This refers to the assemblage of procedure culminating in the retrieval of human oocyte(eggs) which is approximated to potentiated spermatozoa in a test tube (In vitro) in a laboratory condition equilibrated to the same physiological condition as obtains in the normal human environment (in vivo, within the womb). It thus involves fertilization outside the human body and without sexual intercourse.
In vitro Fertilization (IVF) has enhanced the possibility of pregnancy even in situations thought to be impossible until four decades ago when the first baby, Louisa Brown in Great Manchester City, United Kingdom, was born using this technology.
When selecting cases for IVF, the initial diagnostic approach is directed at separating absolutely infertile patients from potentially fertile ones. For example, in cases of bilateral blockage of the Fallopian tubes that are not repairable, refractory (not responsive) anovulation (absence of ovulation), absence of motile sperm or very low sperm count, the couple is absolutely infertile and IVF is the only option.
Those who are potentially fertile are treatable by artificial insemination(IUI) but may fail to conceive after a period of time, appropriate for their age( due to defective egg, sperm, or embryo; patent but malfunctioned tubes; failure of fertilization), IVF is the only alternative as there are no tests to confirm these barriers.
Female Factor
The female is said to have the problem in 30% of cases of infertility, the male also in 30% while 20% is from the contribution by both parties. The commonest cause of infertility, particularly in our environment is tubal problems and most patients requiring IVF suffer from tubal disease. Tubal surgery is usually not an effective, especially where there is peritubal adhesions, thickening of the tubal wall, irreparable damage to the ciliary epithelium within the tubes, and severely damaged fimbria (ends) of the tube. When there is pathological swelling of one or both tubes, Hydrosalpinx, may result in a 50% decline in implantation rate during IVF and may require surgery prior to the procedure. A high level of chlamydial antibody indicates tubal disease as Chlamydia can present as an asymptomatic infection while causing silent ciliary damage in the tubes.
Chances of successful IVF are less in abnormally shaped uterine cavities than in a normally shaped small uterine cavity. Hence fibroid encroaching into the uterine cavity should be removed prior to IVF.
Another condition that may require IVF is endometriosis, a situation where active endometrial tissues (Tissues that line the womb of a woman) are found anywhere other than the endometrial cavity. In this condition, the IVF results are similar no matter the severity of the condition, and the success rate is less than that of women with tubal factor.
Age is a major determinant of fertility outcome. This is due to the waning ovarian that is associated with aging. In advanced ovarian age, as detected by increased cycle day 3 FSH(Follicle Stimulating Hormone) or Estradiol levels, there is reduced IVF outcome and egg donation or modified IVF stimulation protocols are alternatives.
Male factor
If the total sperm count is < 10million, sperm motility is < 30%, or there is abnormal spermatozoon morphology >60%, IVF is indicated. In severe male factor infertility, either of the obstructive or non-obstructive type, micromanipulation techniques can be used with IVF to achieve pregnancy.
In the presence of anti-sperm antibodies, if there is no conception with immunosuppressive drugs, the use of condoms and IUI patients are advised for IVF.
In unexplained infertility, if the patient fails to conceive after 6 cycles of IUI and superovulation(use of drugs to increase the number of follicles that get to maturation in each cycle), or if the woman is greater than 35 years, IVF is advised.
IVF gives better results in young women and success declines in women greater than 40 years due to oocyte problems like genetic or chromosomal defects. Age factor, therefore, should be kept in mind while selecting cases for IVF.
Good physical and emotional condition of the patient improves success rate because of a better response to medication. If there are an existing medical condition, like diabetes mellitus, kidney or liver diseases, prior consultation with a medical specialist is necessary.
In certain situations like premature menopause( menopause before the age of 40 years), when there are genetic disorders, following radiation therapy, or if the ovaries are not available for pickup due to adhesions, parenthood is possible using donor egg or embryo.
Finally, alternatives to IVF exists and must be considered. Surrogacy and adoption are veritable options that should be offered to couples in the face of repeated IVF failures or where IVF is not possible or the results are considered suboptimal.

Find out follow Life Point Fertility Centre Abuja on all social media platform

Today, in vitro fertilization (IVF) is practically a household word. But not so long ago, it was a mysterious procedure for infertility that produced what was then known as "test-tube babies." Louise Brown, born in England in 1978, was the first such baby to be conceived outside her mother's womb.

Unlike the simpler process of artificial insemination -- in which sperm is placed in the uterus and conception happens otherwise normally -- IVF involves combining eggs and sperm outside the body in a laboratory. Once an embryo or embryos form, they are then placed in the uterus. IVF is a complex and expensive procedure; only about 5% of couples with infertility seek it out. However, since its introduction in the U.S. in 1981, IVF and other similar techniques have resulted in more than 200,000 babies.

Life Point Fertility Centre is here to enlighten you